References
- Fisher C. Synovial sarcoma. Ann Diagn Pathol 1998;2:401-21. https://doi.org/10.1016/S1092-9134(98)80042-7
- Kransdorf MJ. Malignant soft-tissue tumors in a large referral population: distribution of diagnoses by age, sex, and location. AJR Am J Roentgenol 1995;164:129-34. https://doi.org/10.2214/ajr.164.1.7998525
- Ferrari A, Gronchi A, Casanova M, et al. Synovial sarcoma: a retrospective analysis of 271 patients of all ages treated at a single institution. Cancer 2004;101:627-34. https://doi.org/10.1002/cncr.20386
- Okcu MF, Munsell M, Treuner J, et al. Synovial sarcoma of childhood and adolescence: a multicenter, multivariate analysis of outcome. J Clin Oncol 2003;21:1602-11. https://doi.org/10.1200/JCO.2003.07.008
- Murphey MD, Gibson MS, Jennings BT, Crespo-Rodriguez AM, Fanburg-Smith J, Gajewski DA. From the archives of the AFIP: imaging of synovial sarcoma with radiologicathologic correlation. Radiographics 2006;26:1543-65. https://doi.org/10.1148/rg.265065084
- Singer S, Baldini EH, Demetri GD, Fletcher JA, Corson JM. Synovial sarcoma: prognostic significance of tumor size, margin of resection, and mitotic activity for survival. J Clin Oncol 1996;14:1201-8. https://doi.org/10.1200/JCO.1996.14.4.1201
- Stanelle EJ, Christison-Lagay ER, Wolden SL, Meyers PA, La Quaglia MP. Pulmonary metastasectomy in pediatric/adolescent patients with synovial sarcoma: an institutional review. J Pediatr Surg 2013;48:757-63. https://doi.org/10.1016/j.jpedsurg.2012.09.042
- Spillane AJ, A'Hern R, Judson IR, Fisher C, Thomas JM. Synovial sarcoma: a clinicopathologic, staging, and prognostic assessment. J Clin Oncol 2000;18:3794-803. https://doi.org/10.1200/JCO.2000.18.22.3794
- Gadd MA, Casper ES, Woodruff JM, McCormack PM, Brennan MF. Development and treatment of pulmonary metastases in adult patients with extremity soft tissue sarcoma. Ann Surg 1993;218:705-12. https://doi.org/10.1097/00000658-199312000-00002
- Billingsley KG, Burt ME, Jara E, et al. Pulmonary metastases from soft tissue sarcoma: analysis of patterns of diseases and postmetastasis survival. Ann Surg 1999;229:2-10.
- Lanza LA, Putnam JB Jr, Benjamin RS, Roth JA. Response to chemotherapy does not predict survival after resection of sarcomatous pulmonary metastases. Ann Thorac Surg 1991;51:219-24. https://doi.org/10.1016/0003-4975(91)90789-S
- Predina JD, Puc MM, Bergey MR, et al. Improved survival after pulmonary metastasectomy for soft tissue sarcoma. J Thorac Oncol 2011;6:913-9. https://doi.org/10.1097/JTO.0b013e3182106f5c
- Spurrell EL, Fisher C, Thomas JM, Judson IR. Prognostic factors in advanced synovial sarcoma: an analysis of 104 patients treated at the Royal Marsden Hospital. Ann Oncol 2005;16:437-44. https://doi.org/10.1093/annonc/mdi082
- Song WS, Jeon DG, Park JH, et al. Long term survival of synovial sarcoma and treatment strategy. J Korean Orthop Assoc 2004;39:329-34. https://doi.org/10.4055/jkoa.2004.39.3.329
- Koh KH, Cho EY, Kim DW, Seo SW. Multivariate analysis of prognostic factors in synovial sarcoma. Orthopedics 2009;32:824.
- Hasegawa T, Yokoyama R, Matsuno Y, Shimoda T, Hirohashi S. Prognostic significance of histologic grade and nuclear expression of beta-catenin in synovial sarcoma. Hum Pathol 2001;32:257-63. https://doi.org/10.1053/hupa.2001.22764
Cited by
- Risk Factors Including Age, Stage and Anatomic Location that Impact the Outcomes of Patients with Synovial Sarcoma vol.6, pp.1, 2016, https://doi.org/10.3390/medsci6010021
- Treatment of cardiac synovial sarcoma: experience of two cases vol.13, pp.None, 2016, https://doi.org/10.1186/s13019-018-0771-0
- Usefulness of SS18-SSX antibody as a diagnostic marker for pulmonary metastatic synovial sarcoma vol.16, pp.1, 2016, https://doi.org/10.1186/s13000-021-01110-6